STOCK TITAN

Dare Bioscience (DARE) Stock News, Sep-Nov 2023

DARE NASDAQ

Daré Bioscience, Inc. develops and commercializes women’s health therapies across contraception, fertility, vaginal health, and sexual health. Its updates center on XACIATO, DARE to PLAY™ Sildenafil Cream, and investigational programs such as DARE-HPV and DARE-PTB1, an intravaginal ring program for prevention of preterm birth.

Recurring news themes include financial results, company updates, product availability through prescription and 503B channels, FDA and IND-related development milestones, clinical-program disclosures, and non-dilutive funding from government sources. Coverage also reflects Daré’s public reporting on product candidates, trials, financing, and business development.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.46%
Tags
partnership clinical trial
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5.79%
Tags
conferences
-
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-6.93%
Tags
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-8.63%
Tags
conferences
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.15%
Tags
conferences earnings date
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.02%
Tags
none
-
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.21%
Tags
conferences
-
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.30%
Tags
conferences
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.88%
Tags
none

FAQ

What is the current stock price of Dare Bioscience (DARE)?

Dare Bioscience (DARE) last closed at $0.4290.

What is the market cap of Dare Bioscience (DARE)?

The market cap of Dare Bioscience (DARE) is approximately $8.4M.